Franklin Resources Inc Jounce Therapeutics, Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.64 - $1.99 $2,317 - $7,205	-3,621 Reduced 13.0%	24,226 $26,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $679 - $1,225	249 Added 0.9%	27,847 $65,000
Q2 2022 Aug 11, 2022	SELL	$2.8 - $7.67 $32,628 - $89,378	-11,653 Reduced 29.69%	27,598 $84,000
Q1 2022 May 13, 2022	BUY	$6.01 - $8.54 $216 - $307	36 Added 0.09%	39,251 $267,000
Q4 2021 Feb 11, 2022	SELL	$7.11 - $9.64 $753 - $1,021	-106 Reduced 0.27%	39,215 $327,000
Q3 2021 Nov 12, 2021	BUY	$5.04 - $8.73 $198,177 - $343,272	39,321 New	39,321 $292,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.